京山輕機(000821.SZ):晟成光伏擬對潤陽股份增資
格隆匯6月24日丨京山輕機(000821.SZ)公佈,公司的全資子公司蘇州晟成光伏設備有限公司(簡稱“晟成光伏”)擬以現金出資的方式對江蘇潤陽新能源科技股份有限公司(簡稱“潤陽股份”或“目標公司”)進行增資,增資總額為1.5億元人民幣。增資完成後,晟成光伏持有目標公司股份數額為8,437,500股,佔轉股後目標公司總股本的1.5523%(持股比例以最終目標公司工商變更登記為準)。
潤陽股份下屬子公司(以下簡稱“債務方”)或其關聯方清償晟成光伏2,083萬美元(按1美元=7.2012人民幣,摺合人民幣1.5億元)債務是本次增資的前提條件和全部資金來源。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.